GLUTATHIONE-SR by Thorne Research, New sustained release formula! The process of aging is associated with increased oxidative activity and decreased levels of reduced glutathione. This appears to be especially prominent in individuals experiencing a decline in cognitive function. Conversely, those living over 100 years tend to have higher glutathione reductase activity.
Patent-pending Glutathione-SR from Thorne Research represents a breakthrough in glutathione supplementation. Its sustained release properties protect it from break down by stomach acid and digestive enzymes.
Dosage:1 Capsule bid
|Each Capsule Contains || ||DV% |
| || || |
|Reduced Glutathione** ||175 mg ||* |
|Time-Sorb TM ||75 mg ||* |
|*Daily Value (DV) not established || || |
**Reduced Glutathione in a patent-pending time release matrix-Time-Sorb TM
(high and low viscosity hydroxy-propylmethyl-cellulose USNF and magnesium-citrate-laurate).
| || |
A woman who is pregnant or nursing, or who might become pregnant, should consult a health-care practitioner before using this product.